Pronađeno: 1-5 / 5 radova

Autori: Herbst Roy S

>> Filter: Samo Article i Review

Naslov IMpower110: Updated OS Analysis of Atezolizumab vs Platinum-Based Chemotherapy as First-Line Treatment in PD-L1-Selected NSCLC (Meeting Abstract)
Autori Herbst Roy S  ...  Andric Zoran G  ...  (broj koautora 20) 
Info JOURNAL OF THORACIC ONCOLOGY, (2021), vol. 16 br. 3, Suppl. S, str. S224-S225
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by PD-L1 immunohistochemistry (IHC) assays and blood tumour mutational burden (bTMB): IMpower110 (Meeting Abstract)
Autori Herbst Roy S  ...  Andric Zoran G  ...  (broj koautora 21) 
Info SWISS MEDICAL WEEKLY, (2020), vol. br. , Suppl. 247, str. 31S-32S
Projekat F. Hoffmann-La Roche, Ltd.Hoffmann-La Roche
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC (Article)
Autori Herbst Roy S  ...  Andric Zoran G  ...  (broj koautora 22) 
Info NEW ENGLAND JOURNAL OF MEDICINE, (2020), vol. 383 br. 14, str. 1328-1339
Projekat Roche HoldingGenentech; IMpower110 ClinicalTrials.gov number [NCT02409342]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Impower110: Interim Overall Survival (OS) Analysis of a Phase Iii Study of Atezolizumab (Atezo) Monotherapy Vs Platinum-Based Chemotherapy (Chemo) as First-Line (1L) Treatment in PD-L1-Selected NSCLC (Meeting Abstract)
Autori Herbst Roy S  ...  Andric Zoran G  ...  (broj koautora 20) 
Info JOURNAL FOR IMMUNOTHERAPY OF CANCER, (2020), vol. 8 br. , Suppl. 1, str. A1-A1
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by SP142, SP263 and 22C3 PD-L1 immunohistochemistry (IHC) assays and by blood tumour mutational burden (bTMB): Results from the IMpower110 study (Meeting Abstract)
Autori Herbst Roy S  ...  Andric Zoran G  ...  (broj koautora 20) 
Info ANNALS OF ONCOLOGY, (2019), vol. 30 br. , Suppl. 11, str. 62-63
Projekat F. Hoffmann-La RocheHoffmann-La Roche
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Ispis zapisa u formatu:TXT | BibTeX